Randomized, Controlled Trial of the Medtronic Endeavor Drug-Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions - ENDEAVOR IV


The goal of the trial was to evaluate treatment with the Endeavor zotarolimus-eluting stent (ZES) compared with treatment with the Taxus paclitaxel-eluting stent (PES) among patients with single de novo coronary lesions.